Common use of FTE Commitments Clause in Contracts

FTE Commitments. (a) Subject to Section 3.4(d), for the first year of the Research Term, BMS shall fund research under the Mode of Action Program for [ * ]. (b) Subject to Section 3.4(d), if Exelixis provides BMS with [ * ] Quality Targets by the date [ * ] of the Effective Date, then, subject to Article 11, from such first anniversary until the termination of the Research Term, BMS shall fund research under the Mode of Action Program for [ * ]. (c) Subject to Section 3.4(d), if Exelixis does not provide BMS with [ * ] Quality Targets by the date [ * ] of the Effective Date and if BMS elects pursuant to Section 3.2(b) to extend for [ * ] the date by which BMS could terminate the Research Term under Section 3.2(a), then after such [ * ], BMS' research funding obligations under the Mode of Action Program shall be as follows: (i) BMS shall fund a minimum of [ * ] until the date that is [ * ] of the Effective Date; and (ii) In the event that Exelixis provides BMS with [ * ] Quality Targets by the date that is [ * ] the [ * ] the Effective Date, BMS shall fund [ * ] from such date until the termination of the Research Term; and (iii) In the event that Exelixis does not provide BMS with [ * ] Quality Targets by the date that is [ * ] the [ * ] the Effective Date, BMS may elect to continue the Mode of Action Program through the end of the Research Term but in such event shall fund [ * ] from such date until the termination of the Research Term. (d) At any time during the Research Term, the JMT may adjust the number of FTEs dedicated to the Mode of Action Program for a minimum period of one (1) year. The resulting number of FTEs shall not exceed [ * ] nor fall below the [ * ], as applicable, without the written consent of Exelixis. BMS shall fund all FTEs allocated by the JMT. Exelixis shall have [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.

FTE Commitments. (a) Subject to Section 3.4(d), for the first year of the Research Term, BMS shall fund research under the Mode of Action Program for [ * ]. (b) Subject to Section 3.4(d), if Exelixis provides BMS with [ * ] Quality Targets by the date [ * ] of the Effective Date, then, subject to Article 11, from such first anniversary until the termination of the Research Term, BMS shall fund research under the Mode of Action Program for [ * ]. (c) Subject to Section 3.4(d), if Exelixis does not provide BMS with [ * ] Quality Targets by the date [ * ] of the Effective Date and if BMS elects pursuant to Section 3.2(b) to extend for [ * ] the date by which BMS could terminate the Research Term under Section 3.2(a), then after such [ * ], BMS' research funding obligations under the Mode of Action Program shall be as follows: (i) BMS shall fund a minimum of [ * ] until the date that is [ * ] of the Effective Date; and (ii) In the event that Exelixis provides BMS with [ * ] Quality Targets by the date that is [ * ] the [ * ] the Effective Date, BMS shall fund [ * ] from such date until the termination of the Research Term; and (iii) In the event that Exelixis does not provide BMS with [ * ] Quality Targets by the date that is [ * ] the [ * ] the Effective Date, BMS may elect to continue the Mode of Action Program through the end of the Research Term but in such event shall fund [ * ] from such date until the termination of the Research Term. (d) At any time during the Research Term, the JMT may adjust the number of FTEs dedicated to the Mode of Action Program for a minimum period of one (1) year. The resulting number of FTEs shall not exceed [ * ] nor fall below the [ * ], as applicable, without the written consent of Exelixis. BMS shall fund all FTEs allocated by the JMT. Exelixis shall have [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.